Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary E Gallick

Showing results (81-90 of 114) with videos related to

Pageof 12
Sort By:
Cancer|March 11, 2008
Epithelial to mesenchymal transition in head and neck squamous carcinoma: association of Src activation with E-cadherin down-regulation, vimentin expression, and aggressive tumor featuresMahitosh Mandal, Jeffery N Myers, Scott M Lippman, et al.
Plos One|January 10, 2013
Combined Inhibition of IGF-1R/IR and Src family kinases enhances antitumor effects in prostate cancer by decreasing activated survival pathwaysFarshid Dayyani, Nila U Parikh, Andreas S Varkaris, et al.
Investigational New Drugs|November 27, 2012
A phase 1 study of gemcitabine combined with dasatinib in patients with advanced solid tumorsDavid S Hong, Jennifer Hsing Choe, Aung Naing, et al.
Oncotarget|April 15, 2015
Yes-mediated phosphorylation of focal adhesion kinase at tyrosine 861 increases metastatic potential of prostate cancer cellsTanushree Chatterji, Andreas S Varkaris, Nila U Parikh, et al.
Angiogenesis|July 28, 2006
Src activation of Stat3 is an independent requirement from NF-kappaB activation for constitutive IL-8 expression in human pancreatic adenocarcinoma cellsJose G Trevino, Michael J Gray, Steffan T Nawrocki, et al.
Oncotarget|November 2, 2017
Cabozantinib-induced osteoblast secretome promotes survival and migration of metastatic prostate cancer cells in boneKai-Jie Yu, Jeffrey K Li, Yu-Chen Lee, et al.
Iscience|May 13, 2021
Multiple pathways coordinating reprogramming of endothelial cells into osteoblasts by BMP4Guoyu Yu, Pengfei Shen, Yu-Chen Lee, et al.
Oncotarget|August 28, 2015
Chitosan nanoparticle-mediated delivery of miRNA-34a decreases prostate tumor growth in the bone and its expression induces non-canonical autophagySanchaika Gaur, Yunfei Wen, Jian H Song, et al.
Journal of Proteome Research|July 5, 2017
Proteomics Profiling of Exosomes from Primary Mouse Osteoblasts under Proliferation versus Mineralization Conditions and Characterization of Their Uptake into Prostate Cancer CellsMehmet Asim Bilen, Tianhong Pan, Yu-Chen Lee, et al.
Molecular Cancer Therapeutics|March 30, 2020
Cabozantinib Reverses Renal Cell Carcinoma-mediated Osteoblast Inhibition in Three-dimensional Coculture <i>In Vitro</i> and Reduces Bone Osteolysis <i>In Vivo</i>Tianhong Pan, Mariane Martinez, Kelsea M Hubka, et al.
Pageof 12

Showing results (81-90 of 114) with videos related to

Sort By:
Pageof 12
Cancer|March 11, 2008
Epithelial to mesenchymal transition in head and neck squamous carcinoma: association of Src activation with E-cadherin down-regulation, vimentin expression, and aggressive tumor featuresMahitosh Mandal, Jeffery N Myers, Scott M Lippman, et al.
Plos One|January 10, 2013
Combined Inhibition of IGF-1R/IR and Src family kinases enhances antitumor effects in prostate cancer by decreasing activated survival pathwaysFarshid Dayyani, Nila U Parikh, Andreas S Varkaris, et al.
Investigational New Drugs|November 27, 2012
A phase 1 study of gemcitabine combined with dasatinib in patients with advanced solid tumorsDavid S Hong, Jennifer Hsing Choe, Aung Naing, et al.
Oncotarget|April 15, 2015
Yes-mediated phosphorylation of focal adhesion kinase at tyrosine 861 increases metastatic potential of prostate cancer cellsTanushree Chatterji, Andreas S Varkaris, Nila U Parikh, et al.
Angiogenesis|July 28, 2006
Src activation of Stat3 is an independent requirement from NF-kappaB activation for constitutive IL-8 expression in human pancreatic adenocarcinoma cellsJose G Trevino, Michael J Gray, Steffan T Nawrocki, et al.
Oncotarget|November 2, 2017
Cabozantinib-induced osteoblast secretome promotes survival and migration of metastatic prostate cancer cells in boneKai-Jie Yu, Jeffrey K Li, Yu-Chen Lee, et al.
Iscience|May 13, 2021
Multiple pathways coordinating reprogramming of endothelial cells into osteoblasts by BMP4Guoyu Yu, Pengfei Shen, Yu-Chen Lee, et al.
Oncotarget|August 28, 2015
Chitosan nanoparticle-mediated delivery of miRNA-34a decreases prostate tumor growth in the bone and its expression induces non-canonical autophagySanchaika Gaur, Yunfei Wen, Jian H Song, et al.
Journal of Proteome Research|July 5, 2017
Proteomics Profiling of Exosomes from Primary Mouse Osteoblasts under Proliferation versus Mineralization Conditions and Characterization of Their Uptake into Prostate Cancer CellsMehmet Asim Bilen, Tianhong Pan, Yu-Chen Lee, et al.
Molecular Cancer Therapeutics|March 30, 2020
Cabozantinib Reverses Renal Cell Carcinoma-mediated Osteoblast Inhibition in Three-dimensional Coculture <i>In Vitro</i> and Reduces Bone Osteolysis <i>In Vivo</i>Tianhong Pan, Mariane Martinez, Kelsea M Hubka, et al.
Pageof 12